G Medical Innovations Holdings Ltd (GMVD)
G Medical Innovations Holdings Ltd operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Rehovot, IL. The stock last traded at $0.18, up 1.38% on the session, giving a market capitalisation of $1.8M. On trailing twelve-month figures it carries a trailing P/E of 0.00, a net margin of -315.8%. Its beta of -1.08 implies it has historically moved less than the broad market.
G Medical Innovations Holdings Ltd, along with its affiliated companies, operates as an early-stage commercial healthcare enterprise. It specializes in creating advanced mobile health and remote medical solutions for markets in the United States, China, and Israel. The company's product portfolio features Prizma, a user-friendly medical device that records vital signs, integrates with electronic medical records, and generates reports adhering to clinical standards. Another key offering is the Extended Holter Patch System, a multi-channel wearable biosensor designed for continuous electrocardiogram data collection for up to two weeks. Furthermore, it is developing a Wireless Vital Signs Monitoring System, intended for real-time and ongoing tracking of physiological parameters and biometrics. Beyond its devices, G Medical Innovations provides monitoring services, encompassing both independent diagnostic testing facility oversight and private patient monitoring. The company was established in 2014 and maintains its headquarters in Rehovot, Israel.
G Medical Innovations Holdings Ltd is most often compared with the following Healthcare names: